Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

Cited In for PubMed (Select 16950021)

1.

Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.

Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P, Sandri MT.

Ecancermedicalscience. 2015 Apr 29;9:528. doi: 10.3332/ecancer.2015.528. eCollection 2015. Review.

2.

An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection.

Bountris P, Haritou M, Pouliakis A, Margari N, Kyrgiou M, Spathis A, Pappas A, Panayiotides I, Paraskevaidis EA, Karakitsos P, Koutsouris DD.

Biomed Res Int. 2014;2014:341483. doi: 10.1155/2014/341483. Epub 2014 Apr 9.

3.
4.

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, Mofenson LM, Nesheim S; Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics.

Pediatr Infect Dis J. 2013 Nov;32 Suppl 2:i-KK4. doi: 10.1097/01.inf.0000437856.09540.11. No abstract available.

5.

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.

Uijterwaal MH, Witte BI, Van Kemenade FJ, Rijkaart D, Ridder R, Berkhof J, Balfoort-van der Meij GA, Bleeker MC, Snijders PJ, Meijer CJ.

Br J Cancer. 2014 Mar 18;110(6):1579-86. doi: 10.1038/bjc.2014.34. Epub 2014 Feb 11.

6.

Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.

Zappacosta R, Colasante A, Viola P, D'Antuono T, Lattanzio G, Capanna S, Gatta DM, Rosini S.

Biomed Res Int. 2013;2013:453606. doi: 10.1155/2013/453606. Epub 2013 Nov 24.

7.

Quality of screening with conventional Pap smear in Austria - a longitudinal evaluation.

Rásky É, Regitnig P, Schenouda M, Burkert N, Freidl W.

BMC Public Health. 2013 Oct 23;13:998. doi: 10.1186/1471-2458-13-998.

8.

Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings.

Luu HN, Adler-Storthz K, Dillon LM, Follen M, Scheurer ME.

Clin Med Insights Oncol. 2013 Sep 25;7:247-55. doi: 10.4137/CMO.S12811. eCollection 2013.

9.

The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening.

Hoste G, Vossaert K, Poppe WA.

Obstet Gynecol Int. 2013;2013:610373. doi: 10.1155/2013/610373. Epub 2013 Jul 1.

10.

Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis.

Luu HN, Dahlstrom KR, Mullen PD, VonVille HM, Scheurer ME.

Cancer Med. 2013 Jun;2(3):367-90. doi: 10.1002/cam4.83. Epub 2013 Apr 21. Review.

11.

HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.

Luhn P, Wentzensen N.

Curr Obstet Gynecol Rep. 2013 Jun 1;2(2):76-85.

12.

Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S43-9. doi: 10.1097/LGT.0b013e3182854269.

13.

Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S36-42. doi: 10.1097/LGT.0b013e3182854253.

14.

HPV testing by cobas HPV test in a population from Catalonia.

Lloveras B, Gomez S, Alameda F, Bellosillo B, Mojal S, Muset M, Parra M, Palomares JC, Serrano S.

PLoS One. 2013;8(3):e58153. doi: 10.1371/journal.pone.0058153. Epub 2013 Mar 6. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/e228bdf4-d943-4d44-8e0f-d441dfa80260.

15.

Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test.

Ki EY, Kim HE, Choi YJ, Park JS, Kang CS, Lee A.

Int J Med Sci. 2013;10(2):119-23. doi: 10.7150/ijms.5460. Epub 2012 Dec 30.

16.

A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening.

Patanwala IY, Bauer HM, Miyamoto J, Park IU, Huchko MJ, Smith-McCune KK.

Am J Obstet Gynecol. 2013 May;208(5):343-53. doi: 10.1016/j.ajog.2012.11.013. Epub 2012 Nov 15. Review.

17.

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study.

Legood R, Smith M, Lew JB, Walker R, Moss S, Kitchener H, Patnick J, Canfell K.

BMJ. 2012 Oct 31;345:e7086. doi: 10.1136/bmj.e7086.

18.

Evaluation of the FTA carrier device for human papillomavirus testing in developing countries.

Gonzalez P, Cortes B, Quint W, Kreimer AR, Porras C, Rodríguez AC, Jimenez S, Herrero R, Struijk L, Hildesheim A, Melchers W.

J Clin Microbiol. 2012 Dec;50(12):3870-6. doi: 10.1128/JCM.01698-12. Epub 2012 Sep 19.

19.

Changes in type-specific human papillomavirus load predict progression to cervical cancer.

Depuydt CE, Criel AM, Benoy IH, Arbyn M, Vereecken AJ, Bogers JJ.

J Cell Mol Med. 2012 Dec;16(12):3096-104. doi: 10.1111/j.1582-4934.2012.01631.x.

20.

Laboratory and clinical aspects of human papillomavirus testing.

Chan PK, Picconi MA, Cheung TH, Giovannelli L, Park JS.

Crit Rev Clin Lab Sci. 2012 Jul-Aug;49(4):117-36. doi: 10.3109/10408363.2012.707174. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk